Congenital CMV
Maternal viral and immune dynamics, placental passage, fetal exposure, model comparison, sensitivity, calibration, and surrogate modeling.

Duke Postdoctoral Research · Ongoing methodological development
I develop quantitative methods for two related translation problems across biological scales and study systems. The program combines maternal-placental-fetal CMV modeling with relaxed optimal transport for mapping immune-cell populations between human and non-human primate data.
One program, two translation problems
Congenital CMV transmission spans maternal immune dynamics, placental infection and barrier function, and fetal exposure. Cross-species immune studies introduce a second translation problem because cell proportions, technical effects, marker panels, and even cell subsets can differ between humans and non-human primates.
The unifying contribution is a disciplined process for model comparison. I compare alternative mechanisms, determine what the available observations can identify, and preserve ambiguity when the evidence does not justify a forced match or a single preferred model.
Maternal viral and immune dynamics, placental passage, fetal exposure, model comparison, sensitivity, calibration, and surrogate modeling.
Shared-marker preprocessing, independent clustering, Gaussian summaries, relaxed optimal transport, bidirectional mapping, and uncertainty diagnostics.
Module 1 · Congenital CMV
Ordinary differential equations represent viral and immune dynamics in maternal blood. Spatial or agent-based components describe placental infection and passage, while stochastic components represent variation in fetal exposure. Clinical cohort measurements and placental-organoid experiments provide complementary constraints.
These figures are model diagnostics, not validated predictions of vaccine efficacy. Claims about maternal protection or fetal transmission require project-specific calibration and external validation.
Model selection and computation
I compare candidate mechanistic formulations before selecting calibration targets, use sensitivity analysis to identify influential and weakly identifiable parameters, and evaluate surrogate models that may reduce simulation cost.
Gaussian-process regression, gradient-boosted trees with Bayesian optimization, and physics-informed neural networks are considered for distinct tasks. They are not interchangeable. The appropriate choice depends on data volume, computational cost, uncertainty requirements, and whether biological structure must remain explicit.
Module 2 · Cross-species immune mapping
Marker panels, cell proportions, and technical effects differ across species, so nearest-centroid matching can impose misleading one-to-one correspondences. The workflow uses shared-marker preprocessing, independent clustering, covariance-regularized Gaussian representations, Wasserstein distances, and optimal transport with relaxed marginals.
The mapping is evaluated in both directions and reports top probability, entropy, and unmatched mass. These diagnostics distinguish concentrated correspondences from ambiguous or unsupported matches.
Takeaway
The goal is not to present one preferred simulator or one forced cross-species map. It is to determine which model is appropriate, what the data can identify, and where uncertainty must remain explicit.
View Duke postdoctoral role